These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12208422)

  • 1. Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation.
    Pengo V; Filippi B; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Am J Cardiol; 2002 Sep; 90(5):545-7. PubMed ID: 12208422
    [No Abstract]   [Full Text] [Related]  

  • 2. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation.
    Berge E; Haug KB; Sandset EC; Haugbro KK; Turkovic M; Sandset PM
    Stroke; 2007 Mar; 38(3):1069-71. PubMed ID: 17290027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin G20210A and factor V Leiden polymorphisms in stroke.
    They-They TP; Battas O; Slassi I; Rafai MA; Katumbay DT; Nadifi S
    J Mol Neurosci; 2012 Jan; 46(1):210-6. PubMed ID: 21701789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of prothrombin G20210A mutation in patients with atrial fibrillation: A systematic review and meta-analysis.
    Gandara E; Barboza AG; Vazquez F
    Thromb Res; 2016 Nov; 147():7-9. PubMed ID: 27664389
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism.
    Poli D; Antonucci E; Cecchi E; Betti I; Valdrè L; Mugnaini C; Alterini B; Morettini A; Nozzoli C; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2003 Dec; 90(6):1158-62. PubMed ID: 14652651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of intracardiac thrombosis in patients with atrial fibrillation: factors of hemostasis, markers of inflammation, and genetic factors].
    Zotova IV; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2007; 47(11):46-54. PubMed ID: 18260964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does activated protein C resistance increase the risk of systematic embolism in non rheumatic atrial fibrillation?
    Eikelboom J; Thom J; Van Bockxmeer F; Baker R
    Aust N Z J Med; 1996 Apr; 26(2):243-4. PubMed ID: 8744632
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
    Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.
    Lichy C; Reuner KH; Buggle F; Litfin F; Rickmann H; Kunze A; Brandt T; Grau A
    Cerebrovasc Dis; 2003; 16(1):83-7. PubMed ID: 12766367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke in an infant heterozygous carrier of both Factor V G1691A and the G20210A prothrombin mutation.
    Germanakis I; Stiakaki E; Sfyridaki C; Katampekios S; Danilatou V; Kalmanti M
    Thromb Haemost; 2003 Oct; 90(4):760-3. PubMed ID: 14515201
    [No Abstract]   [Full Text] [Related]  

  • 13. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor V Leiden and prothrombin G20210A mutations in Kirghiz population.
    Gurgey A; Kudayarov DK; Tuncer M; Parlak H; Altay C
    Thromb Haemost; 2000 Aug; 84(2):356. PubMed ID: 10959716
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
    Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
    Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.
    Aznar J; Mira Y; Vayá A; Corella D; Ferrando F; Villa P; Estellés A
    Thromb Haemost; 2004 May; 91(5):1031-4. PubMed ID: 15116266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S; Thomas L; Balme B; Dalle S
    Clin Exp Dermatol; 2009 Dec; 34(8):e811-3. PubMed ID: 19793098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.